April 13, 2017
Register Now for the Cell and Gene Exchange!
Read More
October 18, 2016
Spark Therapeutics Launches Initiative to Improve Access to Genetic Testing for Inherited Retinal Diseases
Read More
March 10, 2016
Spark Therapeutics Announces Launch of aSharedVision, a New Online Resource to Unite and Inform Those Affected by Inherited Retinal Diseases
Read More
October 10, 2015
Spark Therapeutics Announces Results from Trial of SPK-RPE65 for Genetic Blinding Conditions
Read More
December 30, 2014
Spark Therapeutics Appoints Rare Disease Pioneer Dr. Rogerio Vivaldi as Chief Commercial Officer
Read More
X